Conversations with Leaders

Advances in the treatment of chronic kidney disease: Emerging role of SGLT-2 therapy

Moderator, Dr. Pelin Batur discusses advances in the treatment of chronic kidney disease and the emerging role of sodium glucose co-transporter 2 (SGLT-2) inhibitor therapy with expert nephrology consultants, Dr. Joseph V. Nally and Dr. Jerry Appel, in an 8 chapter video series.

Posted June 18, 2021